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Abstract
This paper features the most interesting presentations and discussions of the 2008 Annual Sessions
of the Society for Cardiovascular Magnetic Resonance, which were held in Los Angeles from
February 1 to 3, 2008.
With more than 1100 attendees, this was the largest of the SCMR meetings ever. Among this year's
highlights were scientific reports on CMR-based risk assessment, non-contrast tissue
characterization, 3 T data, and interventional CMR.
Introduction
This year's Annual Sessions of the Society for Cardiovascu-
lar Magnetic Resonance (SCMR) were held from February
1 to 3 in Los Angeles, California.
The meeting attracted a record number of more than 1100
attendees. The main program was the largest on CMR ever
and featured a total of 41 sessions, among them 15 for
oral abstract sessions, nine clinical, five on experimental
MR, four with case discussions, two offering an informal
"Coffee with the Expert", two on interventional sessions,
two on congenital CMR, one on political aspects, and one
for trainees. 154 invited talks provided state-of-the-art
review on experimental and clinical CMR protocols, con-
troversial aspects and new data. Among this year's areas of
interest were risk stratification of CMR, interventional
CMR, molecular CMR, and tissue characterization in non-
ischemic cardiomyopathies. Among 532 submitted
abstracts, 291 were accepted as posters, 12 as moderated
posters, and 102 for oral presentations.
Workshops
Preceding the main meeting, an introductory physicians'
CMR course (Chairs: Drs. David Bluemke and Peter Buser,
University Hospital, Basel), a workshop on CMR at 3 T
(Chair: Dr. Gerald Pohost), and a workshop on basic and
experimental research in CMR (Chairs: Drs. Sodickson
and Niendorf) were held.
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A 3-day technologists' meeting (Chair Mary Watkins,
Washington University, St. Louis, Missouri) was offered
parallel to the main meeting.
Clinical CMR
Cardiovascular risk assessment: defining better therapeutic targets 
by CMR
Dr. Peter Libby from Harvard Medical School in Boston
opened this year's plenary Focus Session and set the stage
for talks on the spectrum of CMR-derived markers of
atherosclerotic risk, ranging from plaque structure to met-
abolic changes by Dr. Zahi Fayad (Mount Sinai School of
Medicine, New York) and Dr. Hildo Lamb (Leiden Uni-
versity Medical Center, Leiden, NL). Dr. Robert Kloner
(Keck School of Medicine, Los Angeles, CA) introduced
the audience to the targets for secondary prevention,
which were addressed by Dr. Joao Lima (Johns Hopkins
University, Baltimore, MD) and the concluding talk from
Dr. Dudley Pennell (Royal Brompton Hospital, London,
UK), who emphasized prognostic data of CMR based on
in vivo tissue pathology.
Young Investigator Award Session – clinical
The opening plenary session was followed by the Young
Investigator Oral Clinical Presentations. These repre-
sented the abstracts receiving the highest overall grading
among individuals within 5 years of completion of their
training. Opening this very exciting session was the award
winner, Dr. Joseph Selvanayagam (100 [A1]) from Oxford
who presented data on the prognostic importance of late
gadolinium enhancement (LGE). In a study of 152
patients undergoing LGE prior to their first percutaneous
coronary intervention or coronary artery bypass surgery,
they found the presence of new LGE to be the single inde-
pendent predictor of major endpoints (death, non-fatal
myocardial infarction, ventricular arrhythmia terminated
by ICD, unstable angina, and heart failure. Dr. Qi Yang
(102 [A3]) from Beijing presented a study on the use of
contrast enhanced inversion recovery whole heart coro-
nary MRI at 3 T in 22 patients. Compared with x-ray ang-
iography, MRI had an accuracy exceeding 95%. Also using
3 T, Dr. Allison Hays (103 [A4]) of Johns Hopkins Univer-
sity then presented coronary artery velocity data from a
study of rest and handgrip stress in 9 healthy subjects. The
mean increase in peak velocity was nearly 40%.
CMR of myocardial viability
As for the past years, CMR assessment of viability was a
major focus of the SCMR annual meeting. The session
began with a technical report by Dr. Amol Pedneker (112
[A13]) demonstrating that a mid-wall LGE pattern can be
artifactually created when using a low-high phase encod-
ing order and the use of linear phase encoding order is
preferred. Dr. Jose Rodriguez (113 [A14]) from North-
western presented data on microvascular obstruction
using contrast-enhanced CMR as areas of hypoperfusion
in the infarct zone. Among patients followed during their
first week, at 3 months, and 1 year following infarction,
there was progressive reduction of the hypoenhancement
volume. In addition the volume of hypoenhancement
progressively declined when assessed from 1 minute to 25
minutes after contrast injection. The best predictors of
end-systolic volume and ejection fraction at 1 year were
LGE at 15 minutes and the volume of hypoenhancement
at 10 and 15 minutes. Sharon Kirschbaum (116 [A17])
then presented comparative LGE and both 5 and 10 mcg/
kg/min dobutamine viability data regarding chronic total
coronary occlusion. Dysfunctional segments with <25%,
26–50% and >75% transmural LGE demonstrated similar
improvement in systolic wall thickening with 5 and 10
mcg/kg/min of dobutamine while 50–75% transmural
LGE had improved wall thickening with 10 mcg/kg/min.
The session concluded with a presentation by Dr. Grosse-
Wortmann (117 [A18]) examining the inversion time dif-
ferences of the left and right ventricle, concluding that the
difference was likely related to partial volume effect from
the this right ventricle.
CMR of non-ischemic heart disease
Two sessions focused on topics related to experimental
and clinical CMR approaches to Non-Ischemic Heart Dis-
ease.
In a study of 116 patients with suspected LV thrombus,
Dr. Michael Ross and his team from Cornell University
and Duke University Center provided strong evidence that
CMR detects intracavitary thrombi more sensitively than
contrast echo (202 [A63]). Among several presentations
on tissue characterization, Peter Hunold from the Univer-
sity Hospital, Essen, Germany showed data on 5676
patients assessed with CMR. Of those, 1905 patients had
cardiac scars as defined by areas with late enhancement
(205 [A66]). Visualization of scars not only was useful to
differentiate ischemic from non-ischemic injury, but also
to identify the cause of non-ischemic injury, such as HCM,
myocarditis, DCM and storage diseases.
Dr. Anja Zagrosek of Franz-Volhard-Klinik, Berlin
reported on CMR imaging of myocardial edema in 21
patients with acute myocarditis. The authors not only
observed edema as reflected by an increase of normalized
global myocardial signal intensity in T2-weighted images,
but also its decline, which was accompanied by a decrease
of LV mass during the follow-up of 9 months (224 [A85]).
Finally, Tjeerd Germans and co-workers from centers in
Amsterdam, Utrecht and Maastricht (all in The Nether-
lands) could show that CMR-derived strain and strain rate
detects systolic and diastolic dysfunction in 28 HCM
mutation carriers without LV hypertrophy (227 [A88]).Journal of Cardiovascular Magnetic Resonance 2008, 10(Suppl 1):I1 http://jcmr-online.com/content/10/S1/I1
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CMR data on prognosis
With the expansion of CMR centers, there has been con-
siderable interest in the prognostic value of CMR. Dr.
Dall'Armellina (120 [A21]) from Wake Forest University
presented 5 year prognostic data on 200 consecutive
patients with LVEF <55% undergoing dobutamine stress
CMR. Among those with an LVEF of 40–55%, dob-
utamine induced changes in LV wall motion score pre-
dicted adverse cardiac events beyond resting LVEF. Dr.
Pilz (121 [A22]) from the University of Munich then pre-
sented one year prognosis data on 218 patients undergo-
ing adenosine stress CMR. Patients with a normal
adenosine stress CMR had an excellent prognosis (no
events in 99%). Dr. Nijveldt (123 [A24]) from the Univer-
sity Medical Center, Amsterdam then presented data from
60 patients with the first acute myocardial infarction. LGE
microvascular obstruction was associated with wall thin-
ning and reduced improvement in wall thickening, inde-
pendent of LGE transmurality. The results of the first
multicenter international LGE study were then presented
by Dr. Lenge (124 [A25]) from Baylor College of Medi-
cine. Of 183 patients referred for revascularization, the
transmural extent of LGE was inversely related to func-
tional recovery with 72% of dysfunctional segments with-
out LGE demonstrating recovery vs. only 17% of segments
with near complete transmural LGE.
Progress in coronary CMR imaging
While coronary multidetector computed tomography
(MDCT) angiography has captured the attention of many,
increased attention has been turning to coronary MRI due
to the lack of ionizing radiation and iodinated contrast.
The coronary MRI session started with a presentation by
Dr. Liu (126 [A27]) (Northwestern University, Chicago,
IL) who performed coronary MDCT angiography and
whole heart coronary MRI in18 patients with increased
epicardial calcium. Using oral beta blockers and nitroglyc-
erin in both groups, whole heart coronary MRI was found
to be superior to 64-slice MDCT. In the same session, Dr.
Bernhard Gerber (128 [A29]) (Cliniques Universitaires,
Brussels, BE) presented data on a head-to-head compari-
son of whole-heart coronary MRI and 40–64 slice MDCT.
While MDCT had greater success in acquiring interpreta-
ble images, among interpretable segments and vessels,
coronary MRI and MDCT had similar accuracy. Finally,
Dr. Macdedo (127 [A28]) from Johns Hopkins presented
provocative data from the Multi-Ethnic Study of Athero-
sclerosis (MESA) that coronary wall thickness was
increased among their subjects with ≥2 CAD risk factors.
These same investigators also presented data that lower
heart rate and longer rest periods were associated with
improved coronary wall imaging.
Toward a better understanding of cardiovascular risk
The cardiovascular risk session started with a presentation
by Dr. Michael Chuang (133 [A34]) (Beth Israel Deacon-
ess Medical Center, Boston, MD) on lean and obese sub-
jects from the Framingham Heart Study Offspring cohort.
Across all subjects, myocardial contraction fraction (ratio
of LV stroke volume to myocardial volume) was greater in
women and LV ejection fraction was greater in obese vs.
lean subjects. There were two CMR spectroscopy (CMRS)
abstracts: Dr. Rutger van der Meer (134 [A35], 135 [A36])
(Leiden University Medical Center, Leiden, NL) then pre-
sented provocative CMRS data in 43 healthy male subjects
showing that age was significantly correlated with inter-
ventricular septal triglyceride content. These same investi-
gators also demonstrated data that a short-term excessive
dietary fat intake led to increased hepatic triglyceride con-
tent, but no change in myocardial triglyceride content.
The session concluded with a presentation by Dr. Oliver
Rider (137 [A38]) (University of Oxford, UK) who pro-
vided CMR evidence that increased body mass index cor-
related with positively with LV and RV mass. With the
transition from normal to overweight, and an increase in
serum leptin, there was an increase in LV and RV mass, but
no change in LV and RV volumes.
CMR endpoints and clinical trials
The excellent interstudy reproducibility and lack of ioniz-
ing radiation with CMR renders it the most attractive
imaging technique for clinical trials. As Dr. Steven
Dymarkowski from University Hospital, Leuven, BE
pointed out, the current steady state free precession
(SSFP) cine MR provides even better interstudy reproduc-
ibility than has been previously reported for gradient echo
cine CMR. Dr. Nathaniel Reichek of St. Francis Hospital,
New York indicated that the better interobserver and
interstudy reproducibility of CMR for quantifying LV
mass, compared to echocardiography, permits a consider-
able reduction in sample size of approximately 50
patients vs. 1000 patients to indicate a drug effect. Dr.
Raymond Kim reported results of a multicenter study on
LGE in acute myocardial infarction. LGE CMR had a 94%
accuracy for showing infarct in proper distribution of the
culprit artery as verified by angiography.
Moderated poster presentations – clinical
As always, the moderated poster sessions were a highlight
of the meeting, providing the opportunity for the authors
to present their work to attendees in an intimate setting
accompanied by wine and cheese. Dr. Meear Sekar (301
[A104]) of Northwestern University, Chicago presented
quantitative data comparing Doppler with CMR phase
velocity assessment of aortic regurgitation. Dr. Noriko
Oyama (302 [A105]) from the Beth Israel Deaconess
Medical Center, Boston reported on the novel finding of
relationship of CMR epicardial fat to gender and age. ThisJournal of Cardiovascular Magnetic Resonance 2008, 10(Suppl 1):I1 http://jcmr-online.com/content/10/S1/I1
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was followed by the award-winning presentation of Dr.
Mirja Neizel (303 [A106]) from University Hospital, Hei-
delberg, Germany on strain-encoded (SENC) imaging of
myocardial function after acute myocardial infarction.
Among 14 patients with acute infarction, quantitative cir-
cumferential strain was significantly impaired in visually
hypo- and akinetic regions on cine CMR (vs. normoki-
netic segments). Dr. He (304 [A107]) of the Royal Bromp-
ton Hospital, London, UK presented data from their
extensive experience with thalassemia patients and T2*
assessment of myocardial iron. Curve fitting using a trun-
cation model was the most accurate and most reproduci-
ble. The session finished with a presentation by Dr. Flett
(305 [A108]) from the Heart Hospital of London on the
use of real time cine CMR to identify patients with marked
septal flattening as being a very specific sign for patients
with pericardial constriction.
CMR vs. CT in vascular and coronary disease
The value of coronary MDCT was discussed by Dr. Mat-
thew Budoff (David Geffen School of Medicine, Los Ange-
les, CA). MDCT appears to be an excellent technique for
excluding coronary artery stenosis in selected patients.
The assessment of plaque characteristics in coronary ves-
sels by CT however is still limited and there is a lack of
clinical validation data. MRI is a versatile tool to assess
many features of atherosclerosis. As an example, MRI
techniques are being developed for the in vivo assessment
of plaque vulnerability by investigating mechanical stress
on the fibrous cap. Both CT and MRI are still hampered
for a thorough assessment of plaque components and vul-
nerability in coronary vessels by insufficient spatial reso-
lution and limitations due to motion artifacts. Vascular
wall imaging in larger vessels (carotids, aorta) is promis-
ing for serial monitoring of atherosclerosis and the evalu-
ation of therapy.
First-pass perfusion CMR
In the session on the current status of perfusion-CMR, Dr.
Norbert Wilke (University of Florida, Gainsville, FL) dem-
onstrated the performance and current limitations of 3 T
perfusion imaging versus 1.5 T. Dr. Peter Gatehouse
(Royal Brompton Hospital, London, UK) addressed the
potential as well as the so far unresolved issues of absolute
quantification of myocardial perfusion calculated from
first-pass data.
More clinical talks focused on the diagnostic and prognos-
tic performance power of established CMR perfusion pro-
tocols. Dr. Jürg Schwitter (Universitätsspital Zurich,
Switzerland) highlighted the international multicenter,
multivendor trial called MR-IMPACT (Magnetic Reso-
nance Imaging for Myocardial Perfusion Assessment in
Coronary artery disease Trial). This largest trial performed
so far in 18 centers in Europe and the US was recently pub-
lished [1] and demonstrated an excellent and superior
diagnostic performance of CMR perfusion vs. single-pho-
ton emission computed tomography utilizing invasive
coronary angiography as the standard of reference. Dr.
Eike Nagel (King's College, London, UK) presented an
overview of the growing body of literature on the prog-
nostic value of first-pass CMR perfusion. In fact, a normal
of first-pass CMR perfusion or dobutamine stress CMR
test goes along with an excellent prognosis matching that
of healthy subjects.
Finally, Dr. Rohan Dharmakumar (Northwestern Univer-
sity, Chicago, IL) reviewed experimental and preliminary
human experiments exploring an oxygen-level dependent
CMR technique to detect myocardial ischemia.
Vascular MR
Continuing developments in the field of gradient hard-
ware and pulse sequence design, parallel imaging, the
migration to higher field strengths and the clinical intro-
duction of novel intra-vascular contrast agents have
advanced the field of vascular MR significantly over the
past years. The combination of these advances allow for
acquiring time-resolved, high spatial resolution MR angi-
ograms with small doses of contrast agents. The most sig-
nificant advance, however, has been the emerging ability
of contrast-enhanced MRA to provide information on
organ perfusion, in addition to vascular morphology.
Quantitative perfusion data can be obtained by tracking
contrast enhancement in main organ arteries in relation
to the enhancement of the target organ itself. An impor-
tant potential application is the comprehensive assess-
ment of renovascular disease: While MRA can detect or
rule out renal artery stenosis, organ enhancement tech-
niques enable the assessment of renal parenchymal per-
fusion, all with just a small bolus of contrast agent.
Experimental and basic/non-clinical CMR
CMR @ 3.0 T – solved and unsolved problems
The capabilities of MR technology at high-field promise to
translate into extra diagnostic value in CMR imaging, not
only by streamlining structural and functional imaging,
but also by facilitating targeted tissue characterization and
improving access to physiological information. It stands
to reason that all these developments might culminate in
a paradigm shift for the translation of basic research into
clinical MRI, although high-field MRI has been regarded
as one of the most challenging MRI applications, because
of constraints associated with magnetic field inhomoge-
neities and localized tissue heating due to RF power dep-
osition, as emphasized by Dr. Michael Jerosch-Herold
(Brigham & Women's Hospital, Harvard Medical School,
Boston, MA, USA).Journal of Cardiovascular Magnetic Resonance 2008, 10(Suppl 1):I1 http://jcmr-online.com/content/10/S1/I1
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High-field imaging strategies are also appealing for the
capture of dynamic events through the powerful synergy
with parallel imaging strategies. The merits of otherwise
unattainable SNR combined with improvements in acqui-
sition speed promise to further advance real time imaging,
as discussed by Dr. Krishna Nayak (University of Southern
California, Los Angeles, CA). Despite some appreciable
tradeoffs associated with high-field imaging – e.g. the
quality degradation of steady-state free precession
sequences – the promise of high-field real time CMR has
been recognized both as a driver and as a beneficiary of
the move towards 3.0 T many-channel MR systems. The
benefits of high-field MR may be exploited in numerous
ways as demonstrated for MR angiography by Paul Finn
(University of California, Los Angeles, CA); to facilitate
continuous volumetric acquisitions with previously unat-
tainable temporal resolution; or to increase anatomic cov-
erage or spatial resolution within a given imaging time,
allowing comprehensive scanning of any target vessel ter-
ritory, while avoiding the frequently-encountered diffi-
culty of truncated anatomy; or to improve temporal
resolution of time-resolved MRA down to 2–4 s to clearly
distinguish arterial from venous phases, without substan-
tially sacrificing the spatial resolution; or to evaluate con-
trast dynamics. Initial experience at 3.0 T suggests that
higher field strengths in conjunction with tailored RF coil
array designs may enable coronary MRA with sub-millim-
eter spatial resolution together with otherwise unattaina-
ble volume coverage as reported by Dr. Debiao Li
(Northwestern University, Chicago, IL, USA). However,
the issue of the off-resonance sensitivity of SSFP-tech-
niques remains a concern, which has prompted the come-
back of gradient-echo imaging techniques in coronary
artery imaging.
Parallel and rapid imaging
Imaging speed becomes an increasingly significant limita-
tion as new CMR applications are explored. The advent of
parallel imaging introduced a new means of acceleration.
Dr. Jeffrey Tsao (Novartis Inc, Cambridge, MA, USA)
pointed out that the resulting efficiency and speed gain
can be clinically exploited in a number of ways, ranging
from enhancement of spatial and temporal resolution,
efficient volumetric imaging, to streamlining of CVMR
workflow. He demonstrated that, for dynamic imaging
applications including left ventricular function or local
wall thickness assessment, first pass perfusion imaging,
contrast enhanced MRA and flow imaging, imaging tech-
niques that exploit spatio-temporal correlations in the
data may be a preferred means of achieving high accelera-
tions, given their favourable SNR behaviour as compared
to sensitivity encoding based approaches. Of course, these
"spatio-temporal" acceleration techniques may be com-
bined with parallel imaging for further improvements in
imaging speed and/or coverage.
Dr. Sebastian Kozerke (University and ETH Zurich,
Zurich, Switzerland) reported that high levels of accelera-
tion have recently become possible with many-receiver
MR-systems. He described the critical role of cardiac sur-
face RF coil arrays, a key enabling factor for high accelera-
tions; together with prevailing trends towards 32+ receiver
channels and high-field imaging (i.e. 3 T and beyond).
The incremental diagnostic value promised by highly
accelerated parallel imaging and ergonomic requirements
are likely to motivate technological developments, includ-
ing innovative cabling methods, or even wireless coil con-
nectivity. A move towards 64-bit reconstruction hardware
and parallel computation has been recognized as an
important step in overcoming current memory and per-
formance constraints on image reconstruction for many-
channel volumetric acquisitions. An important develop-
ment in this context is the move towards coil array com-
pression to reduce the computational load and
reconstruction times.
Dr. Vivek Muthurangu (University College, London, UK)
provided several examples of highly parallel imaging strat-
egies, including single breath-hold whole heart cine MRI
for rapid assessment of cardiac function, which improves
patient comfort and eliminates the risk of slice registra-
tion errors.
Dr. Peter Kellman (National Heart, Lung and Blood Insti-
tute, Bethesda, MD, USA) discussed clinical cardiac appli-
cations including myocardial perfusion and delayed
enhancement imaging. He illustrated how parallel imag-
ing could provide improved coverage and facilitate the
suppression of "dark rim" artifacts in myocardial per-
fusion imaging, which may mimic subendocardial per-
fusion deficits. He also presented an automatic free-
breathing, late enhancement imaging method with
improved SNR, rendering it particularly suitable for the
assessment of patients with arrhythmia or limited compli-
ance.
Dr. Gerhard Laub (Siemens, Medical Systems, Los Ange-
les, CA, USA) presented time-resolved contrast enhanced
MRA as another imaging application that benefits from
accelerated imaging. He discussed how parallel imaging
can be used to achieve improved vessel sharpness and
delineation, and improved separation of arterial and
venous phases.
New RF coil design
In CMR, where maximum spatial and temporal resolution
is needed, the design of optimized RF-coils is particularly
important. Designs presented in this session included coil
arrays for proton and non-proton CMR, with a trend to
increasing number of array elements. Improvements in
imaging speed or spatial resolution were demonstrated. InJournal of Cardiovascular Magnetic Resonance 2008, 10(Suppl 1):I1 http://jcmr-online.com/content/10/S1/I1
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addition to phased array receiver technology, parallel RF-
transmission may in particular represent a major develop-
ment to overcome SAR-limitations at ultra-high magnetic
fields, and to reduce imaging time by improved volume
selection.
Metabolic CMR studies
CMRS is the only technique that allows for a non-invasive
assessment of metabolism in the heart. While a number of
proton and phosphorous-31 CMRS studies have been
reported in humans and animal models showing feasibil-
ity and providing early insights as proof of principle, a
novel approach to increase the sensitivity of Carbon-13
CMRS by five orders of magnitude, using hyperpolarizing
Carbon-13 compounds, was demonstrated in two presen-
tations (Arnaud Comment, Ecole Polytechnique Fédérale
de Lausanne, Lausanne, Switzerland and Damian Tyler,
University of Oxford, UK). Although the application of
this technique in animal models showed its impressive
potential, the transfer to clinical use remains yet to be
demonstrated.
Young Investigator Award Session (non-clinical)
Interesting papers presented at this session included
reports on advancements in small-field-of-view black
blood imaging using fast spin echo sequences, accelera-
tion of 3-dimensional tagging, and diffusion MRI to assess
fiber changes occurring during development from fetal to
adult heart. Of particular relevance was a study presented
by Sebastiaan Hammer from Leiden University Medical
Center, Leiden, The Netherlands (106 [A7]): Combining
proton CMRS and CMR imaging, the researchers could
demonstrate that substantial weight loss in obese patients
with Type 2 diabetes mellitus not only eliminated the
need for additional insulin supplementation, but also
resulted in improved left ventricular function and reduced
myocardial triglyceride levels. This work demonstrates the
potential of CMR to combine metabolic and functional
information for a more comprehensive diagnosis of heart
disease.
Unmet needs in CMR
This session aimed to bridge the gap between current prac-
tice of CMR and the level where this technique should ide-
ally be. A top ten list identified the most important needs
in CMR to be addressed by future studies, including, for
example, CMRS or molecular imaging. The complexity of
CMR in clinical practice and the required user expertise
were identified as major shortcomings of this versatile
technique, currently preventing a more widespread use
and disadvantaging CMR against CT. The industry and
several professional groups are currently addressing this
issue.
Interventional CMR
At the interventional cardiovascular MRI workshops,
numerous innovations and novel approaches were pre-
sented, such as interactive, real-time MRI workstations for
multi-purpose use for interventional studies (Dr. Juan
Santos, Stanford University, Stanford, CA, USA and Dr.
Michael Guttman, NIH, Bethesda, MD, USA), dual-
modality fusion systems (Dr. Perry Radau, Sunnybrook
Hospital, Toronto, Canada), new catheter, control and
tracking systems (Dr. Albert Lardo, Johns Hopkins Uni-
versity, Baltimore, MD, USA and Dr. Eigil Samset,
Brigham and Women's Hospital, Boston, MD, USA and
University of Oslo, Oslo, Norway). Dr. Amish Raval of
University of Wisconsin at Madison emphasized that real-
time interventional CMR will be useful not to complicate
successful standard procedures but to enable or enhance
otherwise complex procedures. Dr. Dana Peters of Beth
Israel Deaconess Medical Center, Boston, MD showed
that the volume of the ablation-related scar as assessed by
CMR predicted success or failure of radiofrequency abla-
tion of atrial fibrillation.
During oral abstract presentations, Dr. Aaron Bell of Kings
College London described MRI cardiac catheterization in
patients with single ventricle physiology congenital heart
disease (209 [A70]). Unlike available modalities, CMR
catheterization measured differential pulmonary vascular
resistances when there were multiple sources of pulmo-
nary flow, invaluable in surgical management. Dr. Elmar
Spuentrup of University of Cologne, Germany reported
on preclinical experiments with EP-3600 collagen-specific
gadolinium-based contrast for myocardial stress imaging
(207 [A68]). In a pig myocardial stenosis model during
adenosine stress, EP-3600 exhibited differential myocar-
dial accumulation and retention for over 20 minutes. If
further corroborated, this might enable steady-state high-
resolution perfusion imaging, or even possibly treadmill
exercise stress MRI. Dr. Kanishka Ratnayaka of National
Institutes of Health, Bethesda, MD and Childrens
National Medical Center described fusion of CMR imag-
ing and live X-ray to guide antegrade catheter treatment of
spontaneous membranous ventricular septal defect in
swine (109 [A10]). X-ray simplified the procedure and
halved radiation compared with conventional techniques.
Dr. Henry Halperin of Johns Hopkins University, Balti-
more, MD presented early clinical electrophysiology cath-
eter experiments conducted wholly under CMR in human
subjects. He also demonstrated visually stunning real-
time images combined with 3-dimensional volumetric
renderings from prior examinations.Journal of Cardiovascular Magnetic Resonance 2008, 10(Suppl 1):I1 http://jcmr-online.com/content/10/S1/I1
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Congenital CMR
CMR of tetralogy of fallot
A focus of CMR in congenital heart disease was a session
on CMR in Tetralogy of Fallot. CMR was shown as an
important technique for monitoring the major residual
lesion after total correction – pulmonary regurgitation.
Monitoring of right ventricular volumes and ejection frac-
tion is critical in determining the need and timing of pul-
monary valve replacement (PVR). Dr. Karen Ordovas
(Department of Radiology, University of California
School of Medicine, San Francisco, CA, USA) indicated
that when the end systolic volume index exceeded 95 ml/
m2, the total and effective ejection fractions were reduced
below 40% and 25% respectively. Dr. Alexander van
Straten from Leiden University Medical Center, Leiden,
NL, showed in PVR that RVEDV and RVESV decreased in
most patients at 8 months postoperatively, with little fur-
ther reduction at 20 months. A favorable postoperative
response was predicted by a preoperative RVEDV index of
less than 160 ml/m2. Recurrent pulmonary regurgitation
occurred in about 44% of patients. Dr. Andrew Taylor of
Great Ormond Street Hospital in London, UK reported
that transcatheter PVR was only suitable if the pulmonary
annulus was 22 mm or less. CMR was found to be impor-
tant in determining the size and shape of the RV outlet
region in order to determine the suitability of transcathe-
ter PVR. CMR was especially useful for determining if the
left coronary artery might be jeopardized during the pro-
cedure.
What's new in congenital CMR?
In this session on novel approaches in congenital CMR,
Dr. Heynric Grotenhuis of Leiden University Medical
Center, Leiden reported on the use of phase contrast CMR
to demonstrate reduced aortic distensibility and aortic
elasticity in patients after arterial switch procedure. Aortic
root dilation and reduced elasticity were associated with
aortic regurgitation and reduced left ventricular function
(215 [A76]). Dr. Craig Broberg of Oregon Health and Sci-
ence University, Portland proposed a previously described
Look-Locker technique to estimate the distribution vol-
ume of gadolinium chelate in the myocardium. An
increased distribution volume in Eisenmenger patients
and patients years after repair of transposition was inter-
preted as evidence of diffuse myocardial fibrosis (216
[A77]). This diffuse fibrosis is less readily recognized than
replacement fibrosis occurring after myocardial infarc-
tion.
Best Technologist Abstract
Ricardo Wage (Royal Brompton Hospital, London, UK)
received this year's best technologist abstract award for his
presentation on technical considerations for the CMR
assessment of the mitral valve.
Best Manuscript Award of the Journal of Cardiovascular 
MR (JCMR)
Dr. Ann Bolger (UCSF, San Francisco, CA and Linköping
University, Sweden) received the Gerald Pohost Best Man-
uscript Award of the Journal of Cardiovascular Magnetic Res-
onance  (JCMR) for her paper "Transit of Blood Flow
through the Human Left Ventricle Mapped by Cardiovas-
cular Magnetic Resonance" [2]. Editor-in-Chief Dr. Dud-
ley Pennell used the opportunity to remind readers that
the  JCMR  is now available as an open access journal
(online at http://jcmr-online.com).
Conclusion
Among this year's highlights of the Annual Sessions of the
SCMR were scientific reports on CMR-based risk assess-
ment, non-contrast tissue characterization, 3 T data, and
interventional CMR.
In 2009, the 12th Annual Sessions will be held from Feb-
ruary 1 to February 3 in Orlando, Florida.
Additional details on previous and future meetings can be
found on the SCMR website http://www.scmr.org.
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ovascular Magnetic Resonance Spectroscopy; EDV: End-
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Multi-Detector Computed Tomography; MRA: Magnetic
Resonance Angiography; PVR: Pulmonary Valve Replace-
ment; RV: Right Ventricle; RF: Radiofrequency; SAR: Spe-
cific Absorption Ratio; SPECT: Single-Photon Emission
Computed Tomography; SSFP: Steady-state free preces-
sion; T: Tesla.
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